Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Why is the Artemis 2 rocket launch different from all other rocket launches? - 2Manual for Famous Beverages 2024
- 3What to know about the hepatitis B shot — and why Trump officials are targeting it
- 4Figure out How to Plan for Your Web-based Degree monetarily
- 5Outer space conditions hamper sperm's ability to navigate toward an egg
- The most effective method to Safeguard Your Teeth from Acidic Food varieties and Beverages
- Exploring the School Application Cycle: Understudy Bits of knowledge
- Verdicts against social media companies carry consequences. But questions linger
- NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby
- Many European nations want Israel to cancel 19 new settlement plans
- RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats
- Scientists document a death from a meat allergy tied to certain ticks
- The Job of Attorneys: It is Important to Comprehend When Legitimate Help
